如何PCORnet®可以推进市场后证据生成?
Ali B Abbasi1, Lesley H Curtis2, Robert M Califf2
1University of California, San Francisco, CA.
Medical care
|January 8, 2026
概括
以患者为中心的结果研究网络 (PCORnet) 旨在通过有效的证据生成来改善医疗保健. 本评论探讨了PCORnet和类似网络如何在医疗保健实践中简化市场后临床试验.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 临床试验方法论 临床试验方法论
- 医疗信息学 医疗信息学
背景情况:
- 学习式卫生系统的愿景需要有效的证据生成.
- 美国食品和药物管理局 (FDA) 支持加速研究的倡议.
- 市场后的临床试验对于评估现实世界的有效性和安全性至关重要.
研究的目的:
- 讨论PCORnet和类似的国家网络在促进简化临床试验方面的潜力.
- 突出这些网络如何将试验纳入常规临床实践.
- 为了与FDA的目标保持一致,以推进学习型卫生系统.
主要方法:
- 这是一个受邀评论,而不是经验研究.
- 讨论重点是PCORnet.net的功能和潜在应用.
- 分析网络基础设施如何支持简化试验执行.
主要成果:
- PCORnet 和类似的网络为有效的证据生成提供了一个框架.
- 这些网络可以使临床试验融入标准护理.
- 推销后环境中的简化试验可以通过国家网络来促进.
结论:
- 像PCORnet这样的国家网络对于加速发展学习健康系统至关重要.
- 将简化临床试验整合到实践中可以增强证据生成.
- 研究网络和监管机构之间的合作是推动医疗保健研究的关键.
更多相关视频
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
802
11:49Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model
Published on: September 9, 2011
20.9K
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Clinically Relevant Drug Product Specifications: Methods of Establishment
199
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
199
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Methods of Documentation II: POMR
1.4K
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.4K
